Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1941 1
1948 1
1950 9
1951 6
1952 7
1953 4
1954 5
1955 2
1956 2
1957 2
1958 6
1959 3
1960 3
1961 6
1962 6
1963 11
1964 8
1965 8
1966 7
1967 3
1968 9
1969 11
1970 10
1971 11
1972 14
1973 14
1974 11
1975 4
1976 18
1977 11
1978 14
1979 16
1980 16
1981 12
1982 14
1983 18
1984 8
1985 20
1986 22
1987 16
1988 27
1989 25
1990 27
1991 37
1992 19
1993 17
1994 35
1995 40
1996 40
1997 42
1998 50
1999 42
2000 52
2001 53
2002 42
2003 59
2004 66
2005 97
2006 101
2007 123
2008 133
2009 163
2010 200
2011 218
2012 296
2013 330
2014 349
2015 395
2016 416
2017 462
2018 497
2019 527
2020 665
2021 757
2022 898
2023 860
2024 908
2025 20

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8,489 results

Results by year

Filters applied: . Clear all
Page 1
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial.
Zhang X, Liang H, Li Z, Xue Y, Wang Y, Zhou Z, Yu J, Bu Z, Chen L, Du Y, Wang X, Wu A, Li G, Su X, Xiao G, Cui M, Wu D, Chen L, Wu X, Zhou Y, Zhang L, Dang C, He Y, Zhang Z, Sun Y, Li Y, Chen H, Bai Y, Qi C, Yu P, Zhu G, Suo J, Jia B, Li L, Huang C, Li F, Ye Y, Xu H, Wang X, Yuan Y, E JY, Ying X, Yao C, Shen L, Ji J; RESOLVE study group. Zhang X, et al. Among authors: yu p. Lancet Oncol. 2021 Aug;22(8):1081-1092. doi: 10.1016/S1470-2045(21)00297-7. Epub 2021 Jul 9. Lancet Oncol. 2021. PMID: 34252374 Clinical Trial.
Optomechanical dissipative solitons.
Zhang J, Peng B, Kim S, Monifi F, Jiang X, Li Y, Yu P, Liu L, Liu YX, Alù A, Yang L. Zhang J, et al. Among authors: yu p. Nature. 2021 Dec;600(7887):75-80. doi: 10.1038/s41586-021-04012-1. Epub 2021 Dec 1. Nature. 2021. PMID: 34853455
Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II-IIIA (N1-N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study.
Zhong WZ, Wang Q, Mao WM, Xu ST, Wu L, Shen Y, Liu YY, Chen C, Cheng Y, Xu L, Wang J, Fei K, Li XF, Li J, Huang C, Liu ZD, Xu S, Chen KN, Xu SD, Liu LX, Yu P, Wang BH, Ma HT, Yan HH, Yang XN, Zhou Q, Wu YL; ADJUVANT investigators. Zhong WZ, et al. Among authors: yu p. Lancet Oncol. 2018 Jan;19(1):139-148. doi: 10.1016/S1470-2045(17)30729-5. Epub 2017 Nov 21. Lancet Oncol. 2018. PMID: 29174310 Clinical Trial.
3-Methyl-1H-pyrrolo[2,1-c][1,4]oxazin-1-one.
Khan ST, Yu P, Hua E, Ali SN, Nisa M. Khan ST, et al. Among authors: yu p. Acta Crystallogr Sect E Struct Rep Online. 2010 Feb 27;66(Pt 3):o711. doi: 10.1107/S1600536810006951. Acta Crystallogr Sect E Struct Rep Online. 2010. PMID: 21580449 Free PMC article.
Microbial synthesis of wax esters.
Soong YV, Zhao L, Liu N, Yu P, Lopez C, Olson A, Wong HW, Shao Z, Xie D. Soong YV, et al. Among authors: yu p. Metab Eng. 2021 Sep;67:428-442. doi: 10.1016/j.ymben.2021.08.002. Epub 2021 Aug 13. Metab Eng. 2021. PMID: 34391890
8,489 results